The landscape of clinical mycology is constantly changing. New therapies for malignant and
autoimmune diseases have led to new risk factors for unusual mycoses. Invasive …

Invasive fusariosis is a serious invasive fungal disease, affecting immunocompetent and,
more frequently, immunocompromised patients. Localized disease is the typical clinical form …

Fusarium spp. has been associated with a broad spectrum of emerging infections
collectively termed fusariosis. This review includes articles published between 2005 and …

Posaconazole is a second-generation triazole agent with a potent and broad antifungal
activity. In addition to the oral suspension, a delayed-release tablet and intravenous …

Fusarium species are filamentous fungi widely encountered in nature, and may cause
invasive disease in patients with hematologic conditions. Patients at higher risk are those …

Invasive fungal disease (IFD) due to moulds other than Aspergillus is a significant cause of
mortality in patients with malignancies or post haemopoietic stem cell transplantation. The …

The CLSI epidemiological cutoff values (ECVs) of antifungal agents are available for various
Candida spp., Aspergillus spp., and the Mucorales. However, those categorical endpoints …

Objectives The aim of the present study was to evaluate and assess the in vitro activity of
eight drugs, including the new azole isavuconazole, against 81 strains representing 13 …

There is an increasing body of literature on the utility of MALDI-TOF MS in the identification
of filamentous fungi. However, the process still lacks standardization. In this study, we …

Invasive mould infections are an increasing cause of morbidity and mortality globally, mainly
due to increasing numbers of immunocompromised individuals at risk for fungal infections …